1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Survival Strategies for the Global In Vitro Diagnostics Industry

Slowing US and European Markets Demand Alignment with Global Market Needs

Executive Summary

- While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment.
- Prime opportunities include pursuing the underpenetrated Brazil, Russia, India, and China (BRIC) markets; and high-growth IVD segments, such as point-of-care testing (POCT) and self monitoring of blood glucose (SMBG).
- Beyond the BRIC countries, the African IVD market holds early-stage opportunities but the market differences should be understood.
- Due to cuts in reimbursement, clinical laboratories are becoming more open to new technologies that can reduce operating costs.
- An IVD company that leverages external partners for developing cost reducing technologies may have a competitive edge.

Industry Overview and Definitions

•IVD is a $x billion market worldwide and is growing in the mid single-digits. Market revenue consists of product sales of the instruments and consumables.
•IVD are tests that can detect disease, conditions, or infections in patients. Testing occurs outside of the body on specimens like blood, tissue, or urine.
•Customers of IVD products are typically hospitals and laboratories. Customer segmentation varies according to region.
•Much of the US IVD testing volume occurs in hospital laboratories.

Key Market Principles

•The unit in this market is test volume that comes from test utilization, which is most significantly impacted by healthcare access.
•There are improving valuations for diagnostics, which is evident in the companion diagnostics segment.
•There is strong demand for segments using advanced technology like molecular diagnostics and clinical sequencing.

Segment Trends

•IVD segments
oImmunochemistry
oPOCT
oSMBG
oMolecular diagnostics
oMicrobiology
oCoagulation
oHematology
oTissue diagnostics
•Key segment trends
oThe immunochemistry segment is the largest segment and is growing more rapidly than the others.
- In previous years, growth had been driven by volume since these are routine tests and this area of the laboratory is very automated. Presently and moving forward, this segment is more and more driven by growing demand from China and other emerging markets.
oThe molecular diagnostics segment also has an impressive growth trajectory. This segment may reach the size of the POCT segment within 3 years.

Intensifying Competitive Landscape

•Tier I Companies: Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Ortho Clinical Diagnostics (J&J), and Beckman Coulter (Danaher).
•Tier II Companies: Alere, Bayer Diabetes Care, bioMerieux, Sysmex, and Becton Dickinson.
•In the period 2009–2012, Tier I and Tier II have increased their market share at the expense of other weaker competitors. The pace of consolidation is remarkable and will only continue in these challenging market dynamics.
•Further consolidation is expected in the future with M&A guided by strengthening or gaining access to new regions and customer segments.

Table Of Contents

Survival Strategies for the Global In Vitro Diagnostics Industry
Executive Summary 3
Global Market Overview 5
Underpenetrated Markets 12
Opportunities Beyond BRIC 18
Integrating Technology into IVD 24
External Technology Partners 30
Conclusion 36
The Frost and Sullivan Story

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.